New York, NY, 23 April 2010 -- The American College of Cardiology and Elsevier are proud to announce that JACC: Cardiovascular Interventions has been accepted for coverage by Thomson Reuters (formerly Thomson Scientific/ISI) abstracting and indexing services, including the Journal Citation Reports®. The Journal will receive its first impact factor in 2011.
"The Editorial Board and the American College of Cardiology are extremely pleased that the JACC: Cardiovascular Interventions has been accepted by Thomson Reuters," commented Editor-in-Chief Spencer B. King, III, MD. "This coverage will help to further increase dissemination of the journal's content to support our mission to provide the interventional community with a long needed forum for advancing interventional cardiovascular care."
Abstracting and indexing will begin with Volume 1:1 (2008) in Science Citation Index Expanded (also known as SciSearch®), Social Sciences Citation Index®, Current Contents®/Clinical Medicine and Journal Citation Reports/Science Edition.
JACC: Cardiovascular Interventions publishes the pivotal trials that influence clinical practice and inform guidelines. Topics of critical interest to practitioners of interventional cardiovascular medicine are examined in clear and focused reviews by the world's experts, and controversial issues are debated in pro/con features aimed at providing improved insights.
"Coverage by Thomson Reuters clearly acknowledges the high-quality, significant work published in the journal and the continuing efforts of the highly-respected editors, reviewers and the ACC. We at Elsevier would like to thank them all for their contribution to this excellent achievement," stated Elsevier's Cynthia Baudendistel, Executive Publisher, Elsevier.
About JACC: Cardiovascular Interventions
JACC: Cardiovascular Interventions encompasses the entire field of interventional cardiovascular medicine, including cardiac (coronary and non-coronary) peripheral and cerebrovascular interventions. With a circulation of over 10,000, JACC: Cardiovascular Interventions publishes studies that will impact the practice of interventional cardiovascular medicine including clinical trials that provide evidence to inform and alter practice guidelines; experimental studies that point to improved technologies and mechanistic understanding and in-depth discussions of topics of interest by respected experts in the field.
About The American College of Cardiology
The ACC is the world's largest cardiology society with 37,000 members. The College is a leader in the formulation of health policy, standards and guidelines, and is a staunch supporter of cardiovascular research. The ACC also bestows the credential Fellow of the American College of Cardiology upon physicians who meet its stringent qualifications, provides professional education and operates national registries for the measurement and improvement of quality care.
About Elsevier
Elsevier is a world-leading publisher of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including the Lancet (www.thelancet.com) and Cell (www.cell.com), and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include ScienceDirect (www.sciencedirect.com), Scopus (www.scopus.com), Reaxys (www.reaxys.com), MD Consult (www.mdconsult.com) and Nursing Consult (www.nursingconsult.com), which enhance the productivity of science and health professionals, and the SciVal suite (www.scival.com) and MEDai's Pinpoint Review (www.medai.com), which help research and health care institutions deliver better outcomes more cost-effectively.
A global business headquartered in Amsterdam, Elsevier (www.elsevier.com) employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC (www.reedelsevier.com), a world-leading publisher and information provider. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).